Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Device experts set sights on GHTF: European Commission's Medical Devices Experts Group will discuss the preparation of the EC's 2004-2006 Global Harmonization Task Force chairmanship during Oct. 27-28 Brussels meeting. Eucomed Director General Maurice Wagner will serve as vice-chairman (1"The Gray Sheet" June 30, 2003, p. 9). Also on the agenda are reclassification of total joint implants and reports from Study Group 2, which specializes in adverse event reporting. During SG2's Aug. 27-28 meeting, Chair Carol Herman updated the progress of an adverse event coding tool and a proposal to consolidate all adverse event reporting documents for manufacturers...

You may also be interested in...



International News In Brief

EC considers cost of innovation: EU Health Commissioner David Byrne quashes parliamentary inquiry from MEP Camilo Nogueira Roman (Greens-Spain) on the "right to health" in EU citizens' health rights charter. Adopted by stakeholders last November, the charter contends that individuals should have the right to innovative procedures independent of economic considerations. On June 11, Byrne indicated that the EC Treaty delegates medical care delivery to member states, effectively ending the initiative at the European level. Trade associations will now focus on individual countries...

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 

Hair Supplement Linked To Cases Of Severe Hepatitis In France

France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel